At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,096 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Nesina Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Biguanides
In Brief
An observational study for Surveillance. Completed, enrolled 1,096 participants across 1 site.
Detailed Summary
To examine the safety and efficacy of long-term combination therapy with alogliptin (Nesina) and biguanides in participants with type 2 diabetes mellitus who responded inadequately to treatment with biguanides in addition to diet therapy and exercise therapy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSurveillance
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2011
First PostedOct 2013
Primary CompletionDec 2014
TodayJul 2026
First PostedOct 17, 2013
Enrollment StartJul 1, 2011
Primary CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 12.7 years ago